Short Interest in Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Declines By 30.4%

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 15,600 shares, a decline of 30.4% from the February 29th total of 22,400 shares. Based on an average daily volume of 47,200 shares, the short-interest ratio is currently 0.3 days.

Fresenius SE & Co. KGaA Trading Up 0.1 %

FSNUY stock traded up $0.01 during mid-day trading on Friday, reaching $6.77. 22,091 shares of the stock traded hands, compared to its average volume of 29,481. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.54. Fresenius SE & Co. KGaA has a one year low of $6.33 and a one year high of $8.38. The stock has a market capitalization of $15.12 billion, a PE ratio of 61.55 and a beta of 1.13. The business has a 50-day moving average price of $6.94 and a two-hundred day moving average price of $7.26.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.